| scholarly article | Q13442814 |
| P50 | author | Jean-Pierre J Issa | Q55459879 |
| P2093 | author name string | H Yang | |
| J Jelinek | |||
| Y Wei | |||
| W Lin | |||
| M K Lee | |||
| G Garcia-Manero | |||
| Z H Fang | |||
| W-G Tong | |||
| S-Q Kuang | |||
| P2860 | cites work | Characterization of the human adenylyl cyclase gene family: cDNA, gene structure, and tissue distribution of the nine isoforms | Q28219206 |
| Causal relationship between the loss of RUNX3 expression and gastric cancer | Q28509530 | ||
| Gene silencing in cancer in association with promoter hypermethylation | Q29617274 | ||
| Epigenetic inactivation of a RAS association domain family protein from the lung tumour suppressor locus 3p21.3. | Q30884723 | ||
| Aberrant DNA methylation of p57KIP2 identifies a cell-cycle regulatory pathway with prognostic impact in adult acute lymphocytic leukemia | Q33186068 | ||
| Identification of an overexpressed gene, HSPA4L, the product of which can provoke prevalent humoral immune responses in leukemia patients | Q33288669 | ||
| The hyper-CVAD regimen in adult acute lymphocytic leukemia | Q34123874 | ||
| Promoter hypermethylation of cancer-related genes: a strong independent prognostic factor in acute lymphoblastic leukemia. | Q34327110 | ||
| Silencing of bidirectional promoters by DNA methylation in tumorigenesis | Q34527442 | ||
| Phase 1/2 study of the combination of 5-aza-2'-deoxycytidine with valproic acid in patients with leukemia | Q35848726 | ||
| Concurrent methylation of multiple genes in childhood ALL: Correlation with phenotype and molecular subgroup. | Q38350481 | ||
| Ultradeep bisulfite sequencing analysis of DNA methylation patterns in multiple gene promoters by 454 sequencing. | Q39813815 | ||
| Differential tumor suppressor properties and transforming growth factor-beta responsiveness of p57KIP2 in leukemia cells with aberrant p57KIP2 promoter DNA methylation | Q40238946 | ||
| Cellular networks of human thymic medullary stromas coordinated by p53-related transcription factors | Q40241136 | ||
| Activation of nuclear factor {kappa}B by somatostatin type 2 receptor in pancreatic acinar AR42J cells involves G{alpha}14 and multiple signaling components: a mechanism requiring protein kinase C, calmodulin-dependent kinase II, ERK, and c-Src | Q40382379 | ||
| Implication of the MAGI-1b/PTEN signalosome in stabilization of adherens junctions and suppression of invasiveness. | Q40475289 | ||
| Epigenetic regulation of human telomerase reverse transcriptase promoter activity during cellular differentiation | Q44965351 | ||
| MIRA-assisted microarray analysis, a new technology for the determination of DNA methylation patterns, identifies frequent methylation of homeodomain-containing genes in lung cancer cells | Q47591519 | ||
| The temporal and spatial expression pattern of myosin Va, Vb and VI in the mouse ovary | Q50649124 | ||
| Discovery of novel epigenetic markers in non-Hodgkin's lymphoma. | Q54596898 | ||
| Acute lymphoblastic leukemia | Q79891876 | ||
| Protein expression of a triad of frequently methylated genes, p73, p57Kip2, and p15, has prognostic value in adult acute lymphocytic leukemia independently of its methylation status | Q81685428 | ||
| DNA methylation alterations in the pancreatic juice of patients with suspected pancreatic disease | Q82310389 | ||
| P433 | issue | 8 | |
| P921 | main subject | leukemia | Q29496 |
| lymphocyte | Q715347 | ||
| CpG island | Q1138360 | ||
| P304 | page(s) | 1529-1538 | |
| P577 | publication date | 2008-06-05 | |
| P1433 | published in | Leukemia | Q6534498 |
| P1476 | title | Genome-wide identification of aberrantly methylated promoter associated CpG islands in acute lymphocytic leukemia | |
| P478 | volume | 22 |
| Q39628888 | A genome-wide screen identifies frequently methylated genes in haematological and epithelial cancers |
| Q33754623 | Aberrant DNA methylation and epigenetic inactivation of Eph receptor tyrosine kinases and ephrin ligands in acute lymphoblastic leukemia |
| Q33961765 | Aberrant DNA methylation is associated with disease progression, resistance to imatinib and shortened survival in chronic myelogenous leukemia |
| Q45355262 | Aberrant EPHB4 gene methylation and childhood acute lymphoblastic leukemia |
| Q30773951 | Aberrant hypomethylated STAT3 was identified as a biomarker of chronic benzene poisoning through integrating DNA methylation and mRNA expression data |
| Q45391745 | Aberrant hypomethylation of SALL4 gene is associated with intermediate and poor karyotypes in acute myeloid leukemia |
| Q24655104 | Allele-specific gene expression patterns in primary leukemic cells reveal regulation of gene expression by CpG site methylation |
| Q54357396 | Array-based DNA methylation profiling in acute myeloid leukaemia |
| Q49593223 | Azacytidine in combination with tyrosine kinase inhibitors induced durable responses in patients with advanced phase chronic myelogenous leukemia. |
| Q34318280 | Base-pair resolution DNA methylation sequencing reveals profoundly divergent epigenetic landscapes in acute myeloid leukemia |
| Q38695913 | Biomarkers of susceptibility following benzene exposure: influence of genetic polymorphisms on benzene metabolism and health effects |
| Q27023891 | Cellular signaling and biological functions of R-spondins |
| Q37423780 | Chromatin maps, histone modifications and leukemia. |
| Q35673157 | Clinical significance of aberrant DNA methylation in childhood acute lymphoblastic leukemia |
| Q40080682 | Cord blood DNA methylation and adiposity measures in early and mid-childhood. |
| Q58134756 | Csk-homologous kinase (Chk/Matk): a molecular policeman suppressing cancer formation and progression |
| Q39094566 | DNA methylation of membrane-bound tyrosine phosphatase genes in acute lymphoblastic leukaemia. |
| Q36721411 | DNA methylation profiles at precancerous stages associated with recurrence of lung adenocarcinoma |
| Q35843010 | Deciphering mechanisms of drug sensitivity and resistance to Selective Inhibitor of Nuclear Export (SINE) compounds |
| Q54570256 | Deregulation of FGFR1 and CDK6 oncogenic pathways in acute lymphoblastic leukaemia harbouring epigenetic modifications of the MIR9 family |
| Q45052060 | Do longer formula feeding and later introduction of solids increase risk for pediatric acute lymphoblastic leukemia? |
| Q54347138 | Downregulation of MAGI1 Associates with Poor Prognosis of Hepatocellular Carcinoma |
| Q89497272 | Drug Resistance Biomarkers and Their Clinical Applications in Childhood Acute Lymphoblastic Leukemia |
| Q39633405 | Early life stress enhances behavioral vulnerability to stress through the activation of REST4-mediated gene transcription in the medial prefrontal cortex of rodents. |
| Q39467023 | Effects of benzene and its metabolites on global DNA methylation in human normal hepatic l02 cells |
| Q35740894 | Emerging Pharmacotherapies for Adult Patients with Acute Lymphoblastic Leukemia |
| Q37346213 | Emerging methods for analysis of the cancer methylome |
| Q39445033 | EphrinA5 suppresses colon cancer development by negatively regulating epidermal growth factor receptor stability |
| Q34700660 | Epigenetic inactivation of Notch-Hes pathway in human B-cell acute lymphoblastic leukemia. |
| Q38141135 | Epigenetic regulation of cell signaling pathways in acute lymphoblastic leukemia |
| Q33791902 | Epigenetic silencing of SALL3 is an independent predictor of poor survival in head and neck cancer |
| Q26823403 | Epigenomics of leukemia: from mechanisms to therapeutic applications |
| Q33840913 | Frequent and simultaneous epigenetic inactivation of TP53 pathway genes in acute lymphoblastic leukemia |
| Q39617678 | Frequent epigenetic inactivation of KIBRA, an upstream member of the Salvador/Warts/Hippo (SWH) tumor suppressor network, is associated with specific genetic event in B-cell acute lymphocytic leukemia. |
| Q39752269 | Functional characterization of high levels of meningioma 1 as collaborating oncogene in acute leukemia |
| Q30452637 | Functional proteomics, human genetics and cancer biology of GIPC family members |
| Q36584002 | Gene expression changes in human lung cells exposed to arsenic, chromium, nickel or vanadium indicate the first steps in cancer |
| Q39793806 | Genome-Wide Dna Methylation Profiling Using Infinium ® Assay |
| Q35878552 | Genome-wide DNA methylation profiling of chronic lymphocytic leukemia allows identification of epigenetically repressed molecular pathways with clinical impact |
| Q36402765 | Genome-wide methylation profiling identifies hypermethylated biomarkers in high-grade cervical intraepithelial neoplasia |
| Q39606660 | Genome-wide screen reveals WNT11, a non-canonical WNT gene, as a direct target of ETS transcription factor ERG |
| Q37788000 | Genome‐wide DNA methylation profiling |
| Q36064278 | Genomic Copy Number Variations in the Myelodysplastic Syndrome and Acute Myeloid Leukemia Patients with del(5q) and/or -7/del(7q). |
| Q37374239 | Genomic tools for dissecting oncogenic transcriptional networks in human leukemia |
| Q45252143 | High density DNA methylation array with single CpG site resolution |
| Q85170660 | Hypomethylating agents in acute lymphoblastic leukemia: untapped potential? |
| Q33737079 | Identification of 5 novel genes methylated in breast and other epithelial cancers |
| Q34181789 | Identification of Driver and Passenger DNA Methylation in Cancer by Epigenomic Analysis |
| Q37627410 | Impact of aberrant DNA methylation patterns including CYP1B1 methylation in adolescents and young adults with acute lymphocytic leukemia |
| Q37962001 | Integrated analysis of genetic and epigenetic alterations in cancer |
| Q41473465 | Integrated genetic and epigenetic analysis of childhood acute lymphoblastic leukemia |
| Q35553581 | Integrated genomic analysis of relapsed childhood acute lymphoblastic leukemia reveals therapeutic strategies |
| Q42394189 | Integrative epigenomic analysis identifies biomarkers and therapeutic targets in adult B-acute lymphoblastic leukemia |
| Q47661261 | Loss of Myosin Vb in colorectal cancer is a strong prognostic factor for disease recurrence |
| Q39185993 | MYO5B Is Epigenetically Silenced and Associated with MET Signaling in Human Gastric Cancer |
| Q54266084 | Methylation status ofCEBPAgene promoter in chronic myeloid leukemia |
| Q21245768 | MiR-185 Targets the DNA Methyltransferases 1 and Regulates Global DNA Methylation in human glioma |
| Q34009859 | Microcell-mediated chromosome transfer identifies EPB41L3 as a functional suppressor of epithelial ovarian cancers. |
| Q36807943 | Migration and DNA methylation: a comparison of methylation patterns in type 2 diabetes susceptibility genes between indians and europeans |
| Q37957618 | NKL homeobox genes in leukemia. |
| Q37939947 | PDZ domains: the building blocks regulating tumorigenesis |
| Q38097334 | Pediatric Relapsed or Refractory Leukemia: New Pharmacotherapeutic Developments and Future Directions |
| Q35196159 | Phenotype specific analyses reveal distinct regulatory mechanism for chronically activated p53 |
| Q36262865 | Potential roles of microRNA-29a in the molecular pathophysiology of T-cell acute lymphoblastic leukemia |
| Q38327984 | Preclinical activity of LBH589 alone or in combination with chemotherapy in a xenogeneic mouse model of human acute lymphoblastic leukemia. |
| Q92778325 | Production, purification and characterization of recombinant human R-spondin1 (RSPO1) protein stably expressed in human HEK293 cells |
| Q39029239 | RSPO2-LGR5 signaling has tumour-suppressive activity in colorectal cancer. |
| Q37309797 | Role for tissue-dependent methylation differences in the expression of FOXE1 in nontumoral thyroid glands |
| Q24598596 | SWAN: Subset-quantile within array normalization for illumina infinium HumanMethylation450 BeadChips |
| Q36626700 | Secreted and Transmembrane Wnt Inhibitors and Activators |
| Q28244856 | Stem cell factor SALL4 represses the transcriptions of PTEN and SALL1 through an epigenetic repressor complex |
| Q39283878 | Study of methylation of histone H3 lysine 9 and H3 lysine 27 during X chromosome inactivation in three types of cells |
| Q46074520 | Successful induction therapy with decitabine in refractory childhood acute lymphoblastic leukemia |
| Q50954240 | TCRα rearrangements identify a subgroup of NKL-deregulated adult T-ALLs associated with favorable outcome. |
| Q37901485 | Targeting Epigenetics through Histone Deacetylase Inhibitors in Acute Lymphoblastic Leukemia |
| Q39566623 | The DNA methyltransferase inhibitors zebularine and decitabine induce mitochondria‐mediated apoptosis and DNA damage in p53 mutant leukemic T cells |
| Q36392765 | The R-spondin family of proteins: emerging regulators of WNT signaling |
| Q40996500 | The antihypertensive drug hydralazine activates the intrinsic pathway of apoptosis and causes DNA damage in leukemic T cells. |
| Q37995811 | The clinical relevance of chromosomal and genomic abnormalities in B-cell precursor acute lymphoblastic leukaemia |
| Q37965806 | The role of stem cell factor SALL4 in leukemogenesis |
| Q64965821 | Transcriptional landscape of B cell precursor acute lymphoblastic leukemia based on an international study of 1,223 cases. |
| Q28391757 | Urinary benzene biomarkers and DNA methylation in Bulgarian petrochemical workers: study findings and comparison of linear and beta regression models |
| Q34426853 | Zinc finger protein 382 is downregulated by promoter hypermethylation in pediatric acute myeloid leukemia patients |
Search more.